Cancer Genetics continuing with IPO plans

Contrary to media reports saying otherwise, Cancer Genetics Inc. (Rutherford, N.J.) has not postponed its planned IPO, according to a source familiar with the deal. The source said the market conditions are "not ideal" but added that the company is still actively marketing and talking with investors. Cancer Genetics had not expected to price the offering this week, according to the source, who attributed the reports of a postponement to media expectations that the offering would price this week alongside social media company Facebook Inc. (NASDAQ:FB). ...